108
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Tris(trifluoromethyl) Cyclotriphosphine (CF3P)3: Formation and NMR Spectroscopy

&
Pages 1091-1099 | Received 05 Feb 2009, Accepted 11 Feb 2009, Published online: 28 Apr 2009
 

Abstract

The reaction of trifluoromethyl dichlorophosphine (CF3PCl2) with mild reducing agents results in the formation of CF3-substituted cyclooligophosphines (CF3P) n (n = 3–5). The hitherto unknown cyclotriphosphine (CF3P)3 is described here for the first time and is characterized by multinuclear (31P, 19F) NMR spectroscopy. A full analysis of the 19F NMR signals of (CF3P)3 (X and Y part of [AX3]2BY3 spectrum) is presented.

Dedicated to Professor Marian Mikołajczyk, CBMiM PAN in Łodź, Poland, on the occasion of his 70th birthday.

We thank Dr. Oliver Schön for a sample of CF3PCl2 and for his great help. Financial support from the Department of Chemistry and Biochemistry, Ludwig Maximilian University, is gratefully acknowledged. We thank Prof. Dr. T. M. Klapötke for many helpful discussions and for his continuous support.

Notes

a The relative signs of the coupling constants result from the iterative fitting of the spectrum and are given assuming a negative sign for 1 J PP.Citation 16

a The relative signs of the coupling constants result from the iterative fitting of the spectrum and are given assuming a negative sign for 1 J PP.Citation 16

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.